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SUMMARY – Th e aim was to examine whether the postprocedural change in C-reactive protein 
(CRP) and fi brinogen levels was associated with the extent of periprocedural arterial injury caused by 
endovascular treatment (EVT). Th e study recruited 71 patients undergoing EVT. Eighty-four pa-
tients that underwent angiography served as a control group. CRP and fi brinogen were measured at 
baseline, and at 8, 24 and 48 hours following the procedure. In all experimental group patients, lesion 
complexity, percutaneous transluminal angioplasty (PTA) treated segment length, balloon infl ation 
time and stented segment length were recorded. Th ere was signifi cant increase in plasma CRP and 
fi brinogen levels 48 hours following EVT (p<0.001). Th ere was no signifi cant diff erence in CRP and 
fi brinogen levels among diff erent TASC groups. CRP levels were signifi cantly higher in stent sub-
group compared to PTA subgroup. Signifi cant positive correlation was found between PTA treated 
segment length and CRP increase between 8 and 24 hours following EVT (r=0.313, p=0.02), balloon 
infl ation time and CRP increase in the aforementioned time frame (r=0.270, p=0.03), as well as be-
tween CRP increase at 8 hours and stented segment length (r=0.535, p=0.01). Th is study showed that 
the arterial injury caused by EVT refl ected on the level of infl ammatory biomarkers.
Key words: C-reactive protein; Fibrinogen; Stents; Angiography; Endovascular procedures; Angioplasty
Correspondence to: Tajana Turk, MD, Department of Diagnostic 
and Interventional Radiology, Osijek University Hospital Centre, J. 
Huttlera 4, HR-31000 Osijek, Croatia
E-mail: turk.tajana@gmail.com
Received July 14, 2017, accepted September 15, 2017
Introduction
Despite recent technical advances that have im-
proved endovascular treatment (EVT) for peripheral 
arterial disease (PAD), neointimal hyperplasia and 
subsequent restenosis remain major culprits for failure. 
Balloon angioplasty leads to atherosclerotic plaque 
rupture, exposure of its lipid rich core and activation of 
blood components1. Stent implantation causes imme-
diate biological response of protein, fi brinogen and 
blood cell deposition between stent struts and prolif-
eration of granulation tissue and vascular smooth mus-
cle cells2. Th is process of endothelial healing leads to 
neointimal hyperplasia, which correlates with the ex-
tent of arterial wall injury3.
It has been reported that higher postprocedural 
levels of infl ammatory biomarkers indicate a higher 
risk of restenosis4,5. Both C-reactive protein (CRP) 
and fi brinogen have been established as biomarkers in 
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atherosclerosis, but their exact role remains controver-
sial6. Although CRP is mainly synthesized in the liver, 
it is also produced by vascular smooth muscle cells and 
macrophages in the atherosclerotic plaque7,8. Plasma 
concentration of CRP correlates with the level of its 
synthesis9. In vitro studies have shown that mechanical 
strain leads to local CRP expression in human arter-
ies10. Fibrinogen was found to be associated with both 
the onset and progression of PAD11,12. Apart from be-
ing the key determinant of blood viscosity and throm-
bus formation, fi brinogen is also responsible for neo-
intimal growth by stimulation of vascular smooth 
muscle cells13.
Although the correlation between postprocedural 
levels of infl ammatory biomarkers and EVT has been 
investigated in several studies, the association with the 
extent of periprocedural arterial injury has not been 
completely elucidated.
Th e aim of this study was to examine whether the 
postprocedural change in CRP and fi brinogen levels 
Table 1. Patient characteristics







































DM, n (%) 30 (35.7) 26 (36.6) >0.99*
Hypertension, n (%) 55 (65.5) 51 (71.8) 0.49*
CVD, n (%) 14 (16.7) 10 (14.1) 0.82*
CAD, n (%) 16 (19) 12 (16.9) 0.84*
Smoking, n (%) 45 (53.6) 35 (49.3) 0.63*
Dyslipidemia, n (%) 66 (95.7) 45 (77.6) 0.003*






























*Fisher exact test; †Mann Whitney U test; CAD = coronary artery disease; CVD = cerebrovascular 
disease; DM = diabetes mellitus; PTA = percutaneous transluminal angioplasty; TASC II = Trans-
Atlantic Inter-Society Consensus Document on Management of Peripheral Arterial Disease
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was associated with the extent of periprocedural arte-
rial injury measured by percutaneous transluminal an-
gioplasty (PTA) treated segment length, balloon infl a-
tion time and stented segment length.
Subjects and Methods
Study design
Th is observational single-center cohort study was 
conducted at Department of Diagnostic and Interven-
tional Radiology, Osijek University Hospital Centre, 
Osijek, Croatia between June 2014 and April 2017. 
Before enrolment, all patients provided their written 
informed consent. Th e study was approved by the 
 Ethics Committee of the Osijek University Hospital 
Centre.
Study population
Patients were referred by vascular surgeon for diag-
nostic angiography and/or EVT for PAD. Seventy-
one patients who underwent technically successful 
PTA with or without stent implantation were recruit-
ed. Eighty-four patients who underwent diagnostic 
angiography of lower limbs during the same period 
served as a control group. Th eir demographic charac-
teristics are listed in Table 1. Fontaine classifi cation14 
was used to categorize the severity of PAD. Th e Trans-
Atlantic Inter-Society Consensus Document on Man-
agement of Peripheral Arterial Disease (TASC II)15 
classifi cation was used to categorize the complexity of 
lesions to be treated. Patients on hemodialysis treat-
ment, patients with malignant disease, those with a 
history of surgery, myocardial infarction or coronary 
endovascular intervention in the past 3 months or en-
dovascular intervention on peripheral arteries in the 
last 2 weeks, patients on immunosuppressant therapy 
and those suff ering from or treated for chronic infl am-
matory diseases, and patients with clinical or labora-
tory signs of acute infection (CRP ≥10 mg/L) were 
excluded from the study. Patients who underwent any 
other form of EVT besides balloon angioplasty and 
bare metal stent implantation (such as drug coated 
balloon angioplasty, drug eluting stent implantation, 
stent graft implantation, thrombolysis, thrombectomy, 
etc.) were not included in the study.
Methods
Lower limb arteriography and interventional pro-
cedures were performed by an interventional radiolo-
gist (T.T., O.R., G.S. or T.M.) using standardized pro-
tocol and femoral arterial ipsilateral or contralateral 
access. Th e procedures were performed on iliac and 
femoropopliteal arteries according to TASC II guide-
lines. PTA balloon and stent diameters and length 
were selected according to the vessel diameter and dis-
eased segment length.
Stenting was performed in case of elastic recoil, 
fl ow-limiting dissection or residual stenosis greater than 
30%. During EVT, all patients received a bolus of 5000 
IU of heparin intra-arterially. After EVT, all patients 
received 40 mg of subcutaneous enoxaparine for three 
days. In all patients, localization and complexity of the 
lesion, balloon infl ation time, PTA treated segment 
length, and stented segment length were recorded.
Clinical data
In all patients, demographic data and medical his-
tory were determined using a questionnaire and medi-
cal records. Hypertension was defi ned as blood pres-
sure of >130/90 mm Hg or a history of treatment for 
hypertension. Dyslipidemia was defi ned as a serum 
high-density lipoprotein (HDL) level <1 mmol/L, 
low-density lipoprotein (LDL) level >3 mmol/L, cho-
lesterol level >5 mmol/L, and triglyceride level >1.7 
mmol/L. Diabetes mellitus was defi ned as having fast-
ing blood glucose level >6.4 mmol/L or hemoglobin 
A
1c
 >6% or a history of treatment with antidiabetic 
medications. Coronary artery disease was defi ned as a 
history of myocardial infarction, angina pectoris, or 
coronary revascularization procedures. Cerebrovascu-
lar disease was defi ned as a history of transient isch-
emic attacks, cerebral hemorrhage, stroke, or carotid 
artery revascularization procedure.
Blood sampling
Baseline peripheral venous blood samples were ob-
tained from each patient before angiography or EVT, 
in the morning after overnight fast. Subsequently, ve-
nous blood samples were obtained at 8 hours, 24 hours 
and 48 hours after the procedure. CRP levels were 
measured by an immunoturbidimetric method (Olym-
pus AU480, Beckman Coulter, Tokyo, Japan). Fibrino-
gen levels were measured by a coagulometric method 
(BCS XP, Siemens Healthcare Diagnostics, Marburg, 
Germany). Laboratory values were recorded for each 
patient and compared between the groups.
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Statistical analysis
Data were processed using descriptive statistical 
methods. Mann-Whitney and Kruskal-Wallis tests 
were used on sample comparison. Wilcoxon test and 
Friedman’s test were used to detect diff erences be-
tween dependent samples. Spearman’s rho test was 
used to determine the association between non-nor-
mally distributed variables. Th e level of signifi cance 
was set at alpha of 0.05. Statistical analysis was per-
formed using MedCalc Statistical Software version 
14.12.0 (MedCalc Software bvba, Ostend, Belgium; 
http://www.medcalc.org; 2014).
Results
Th e indication for EVT was mild intermittent 
claudication (Fontaine stage IIA) in 17 (23.9%), mod-
erate to severe claudication (Fontaine stage IIB) in 49 
(69%) and limb ischemia (Fontaine stages III and IV) 
in fi ve (7%) patients. Lesions to be treated were classi-
fi ed as TASC II A in 38 (59.4%), TASC II B in 21 
(32.8%) and TASC II C in fi ve (7.8%) patients. Th ere 
were no patients with TASC II D lesion. No compli-
cations occurred during or following EVT. PTA was 
performed in 44 (72%) and stenting in 27 (38%) pa-
tients. Th e median balloon infl ation time during PTA 
was 360 seconds (s) (interquartile range [IQR] 180-
431.3). Balloon infl ation time for a single patient was 
calculated as the sum of duration of all balloon infl a-
tions performed during vascular intervention. Th e me-
dian length of PTA treated segment was 8 cm (IQR 
6-15) and the median stented segment length was 5 
cm (IQR 4-6).
Th ere was signifi cant increase in both plasma CRP 
and fi brinogen levels in the fi rst 48 hours following 
EVT (p<0.001). Th e increase in CRP and fi brinogen 
levels was also recorded in the control group, but it was 
not statistically signifi cant. CRP levels were signifi -
cantly higher in the study group 24 hours following 
EVT compared to the control group 24 hours follow-
ing angiography (p<0.05). No other statistically sig-
nifi cant diff erence regarding CRP and fi brinogen lev-
els was found between the groups at diff erent time 
points (Table 2).
Among patients with diff erent lesion complexity 
(Table 3), signifi cant increase in both CRP and fi brin-
ogen levels was noted in patients with lesions classifi ed 
as TASC II A and B. Patients with TASC II C lesions 
showed signifi cant increase in CRP (p<0.05), but not 
in plasma fi brinogen levels (p>0.05). No signifi cant 
diff erence in CRP and fi brinogen levels was found at 
examined time points following EVT between diff er-
ent TASC II groups.
Regarding the location of pathology, there was a 
signifi cant postprocedural increase in plasma CRP and 
fi brinogen levels (p<0.001) in patients with femoro-
popliteal interventions and in patients with iliac inter-
ventions. However, there was no signifi cant diff erence 
in postprocedural CRP and fi brinogen elevation be-
tween these two subgroups.
Signifi cant increase in CRP (p<0.001) and fi brino-
gen (p=0.001) levels was found in the subgroup of pa-
tients who underwent PTA, as well as in the subgroup 
that underwent stenting (p<0.001) (Table 4). CRP 
levels were signifi cantly higher (p=0.03) in the stent 
Table 2. Plasma levels of CRP (mg/L) and fi brinogen (g/L) after angiography (control group) and endovascular 
treatment (study group)
 Median (interquartile range)
p†
Control group p* Study group p* All patients





CRP 8 h 3.1 (1.8-5.33) 3.7 (1.9-6.75) 3.3 (1.88-6) 0.42
CRP 24 h 4.75 (2.83-6.8) 6.2 (3.4-11.45) 5 (2.9-9.4) 0.03
CRP 48 h 6.5 (3.25-8.4) 9.1 (4.3-17.7) 7.85 (3.85-14.5) 0.09





Fibrinogen 8 h 3.5 (3.2-4.18) 3.6 (3.13-4.1) 3.55 (3.2-4.1) 0.76
Fibrinogen 24 h 3.8 (3.33-4.68) 4 (3.45-4.85) 3.9 (3.4-4.7) 0.42
Fibrinogen 48 h 4.3 (3.3-5.3) 4.3 (3.7-5.2) 4.3 (3.68-5.23) 0.93
*Friedman’s test; †Mann Whitney U test; CRP = C-reactive protein
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subgroup compared to PTA subgroup 48 hours fol-
lowing EVT.
Regarding the association between elevation of 
CRP and fi brinogen with the extent of periprocedural 
arterial injury (Table 5), signifi cant positive correlation 
was found between PTA treated segment length and 
CRP increase between 8 hours and 24 hours following 
EVT (r=0.313, p=0.02), between balloon infl ation 



























































*Friedman’s test; †Kruskal Wallis test; CRP = C-reactive protein; TASC II = Trans-Atlantic Inter-Society Consensus Document on Man-
agement of Peripheral Arterial Disease classifi cation









































































*Friedman’s test; †Mann Whitney U test; CRP = C-reactive protein; EVT = endovascular treatment; PTA = percutane-
ous transluminal angioplasty
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time and CRP increase in the aforementioned time 
frame (r=0.270, p=0.03), as well as between CRP in-
crease in the fi rst 8 hours following stenting and the 
stented segment length (r=0.535, p=0.01). Th ere was 
no signifi cant positive correlation between fi brinogen 
levels and the extent of periprocedural arterial injury.
Discussion
Endovascular treatment as a minimally invasive 
therapy treats only the diseased vessel segment. How-
ever, dilatation with high-pressure balloons and im-
plantation of stents cause periprocedural injury of the 
arterial wall by endothelial denudation, as well as inti-
mal and medial damage16. Th ese injuries are followed 
by infl ammatory response that often ends with neo-
intimal hyperplasia, a major culprit for long-term 
EVT failure17.
Although CRP and fi brinogen are among the most 
studied infl ammatory biomarkers associated with ath-
erosclerosis, their exact role in the response to arterial 
injury remains unclear. In the current study, CRP level 
increase showed positive correlation with PTA treated 
segment length, balloon infl ation time and stented 
segment length, suggesting that the extent of peripro-
cedural arterial injury correlates with vascular infl am-
matory response. However, we found no such correla-
tion for fi brinogen. Th ese results are consistent with a 
previous study of coronary arteries18, where postproce-
dural increase of CRP correlated with the total stented 
segment length. Confl icting results have been reported 
from the study performed by Wu et al.19, where CRP 
levels were highest 24 hours after percutaneous coro-
nary intervention, but no statistical diff erence regard-
ing infl ammatory response was found between diff er-
ent dilatation pressures and diff erent stented segment 
lengths. We found no similar studies assessing the in-
crease in infl ammatory biomarkers following EVT on 
peripheral arteries.
In this study, signifi cant increase was detected in 
both CRP and fi brinogen levels in patients following 
EVT. Similar increase in infl ammatory biomarkers 
was found after EVT in previous studies, both on cor-
onary and peripheral arteries4,20-23. In the control group, 
the increase in CRP and fi brinogen levels following 
angiography was evident, although not statistically 
signifi cant. Th at mild increase could be attributed to 
arterial puncture and contrast media application.
On subgroup analysis, both PTA and stent groups 
showed statistically signifi cant increase in postproce-
dural CRP and fi brinogen levels. Plasma CRP levels 
were found to be signifi cantly higher in patients 48 
hours following stent implantation compared to PTA 
group. Th ese results can be correlated with morpho-
metric studies24,25 in porcine models where more inti-
mal hyperplasia was found after stenting compared to 
balloon angioplasty, suggesting a more pronounced 
infl ammatory response.
Th e TASC II classifi cation, with its latest update in 
201515, provides guidelines on optimal treatment mo-
dality for PAD based on lesion complexity and loca-
tion. Although more complex lesions are more diffi  cult 
to treat, requiring more endovascular manipulation, in 
our study no signifi cant diff erence was found in CRP 
and fi brinogen levels between diff erent lesion com-
plexity assessed by TASC II classifi cation. Previous 
studies by Schillinger et al.20,22 showed no correlation 
between postprocedural infl ammatory response and 
lesion morphology either.
Th e present study showed that the arterial injury 
caused by EVT refl ected on the level of infl ammatory 
biomarkers. However, there were several limitations to 
Table 5. Correlation between elevation of infl ammatory 
biomarker plasma levels and extent of periprocedural 
arterial injury
Spearman’s rank correlation 
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CRP = C-reactive protein; PTA = percutaneous transluminal 
 angioplasty
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our study. Although the interventions were performed 
according to the TASC II guidelines, angioplasty bal-
loons and stents, as well as balloon infl ation time were 
determined by the operator. Results could have been 
infl uenced by the relatively small number of patients 
and the concomitant use of various drugs not directly 
related to atherosclerotic disease. Diff erent diameters, 
designs and structures of stents could also modulate 
infl ammatory response. Th ere was no follow up to 
study the correlation of our fi ndings with restenosis 
rate.
Although the infl ammatory nature of atherosclero-
sis is well known for almost two decades26, the role of 
infl ammatory biomarkers has not yet been completely 
elucidated. Th e present study assessed the correlation 
between periprocedural arterial injury and infl amma-
tory response measured by CRP and fi brinogen in-
crease, suggesting that the extent of iatrogenic damage 
to the arterial wall could relate to future arterial re-
modeling and subsequent restenosis. Due to the com-
plexity of vascular biology, future studies are warranted 
to clarify the infl ammatory reactions observed.
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Sažetak
JAČINA UPALNOG ODGOVORA NAKON PERIFERNE ENDOVASKULARNE INTERVENCIJE 
OVISI O OPSEGU PERIPROCEDURALNOG OŠTEĆENJA ARTERIJSKE STIJENKE
T. Turk, O. Rubin, G. Šarić, T. Mišević, V. Kopačin, D. Kovač, V. Ivković, V. Farkaš i V. Šerić
Cilj je bio istražiti postoji li povezanost između poslijeproceduralnog porasta serumske razine C-reaktivnog proteina 
(CRP) i fi brinogena ovisno o opsegu periproceduralnog oštećenja arterijske stijenke tijekom endovaskularne intervencije. 
Ispitanici kojima je učinjena dijagnostička angiografi ja (84 ispitanika) činili su kontrolnu skupinu. Ispitanici kojima je uči-
njena endovaskularna intervencija na perifernim arterijama (71 ispitanik) činili su eksperimentalnu skupinu. Svakom ispi-
taniku su prije zahvata te 8, 24 i 48 sati nakon zahvata izmjereni CRP i fi brinogen iz venske krvi. Za svakog su ispitanika 
bilježeni tip i duljina tretirane lezije, vrijeme infl acije balona te duljina stentiranog segmenta. Značajan porast CRP i fi brino-
gena uočen je 48 sati nakon intervencije (p<0,001). Nije bilo značajne razlike u porastu CRP i fi brinogena ovisno o tipu  lezije. 
U skupini bolesnika kojima je postavljen stent 48 sati nakon intervencije uočen je značajan porast CRP, usporedno s ispita-
nicima kojima je učinjena angioplastika balonom. Nađena je pozitivna povezanost porasta CRP između 8 i 24 sata nakon 
intervencije i duljine balonom tretiranog segmenta (r=0,313, p=0,02), kao i vremena infl acije balona (r=0,270, p=0,03). 
 Uočena je pozitivna povezanost porasta CRP prvih 8 sati nakon intervencije i duljine stentiranog segmenta (r=0,535, p=0,01). 
Ovo je istraživanje pokazalo utjecaj opsega periproceduralne lezije arterijske stijenke na poslijeproceduralni porast upalnih 
biomarkera.
Ključne riječi: C-reaktivni protein; Fibrinogen; Stentovi; Angiografi ja; Endovaskularni zahvati; Angioplastika
